Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
about
Aceruloplasminemia: molecular characterization of this disorder of iron metabolismComplete cDNA sequence of human preceruloplasminMolecular pathogenesis of Wilson and Menkes disease: correlation of mutations with molecular defects and disease phenotypesGenotype-phenotype correlations in a mountain population community with high prevalence of Wilson's disease: genetic and clinical homogeneityJuvenile Parkinsonism: clinical and metabolic characteristics.Copper.Ceruloplasmin as a prognostic marker in patients with bile duct cancer.Studies on copper metabolism. XIII. Hepatolenticular degenerationRenal function in Wilson's disease.Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.Studies on copper metabolism. XI. Copper and iron metabolism in the nephrotic syndrome.ABSORPTION OF COPPER IN MALABSORPTION SYNDROMES.Effect of estrogens on copper metabolism in Wilson's disease.DETECTION OF THE HETEROZYGOUS CARRIER OF THE WILSON'S DISEASE GENE.Ceruloplasmin in Wilson's diseaseSERPINE 1 Links Obesity and Diabetes: A Pilot Study.Aceruloplasminemia.A study of toxicity and differential gene expression in murine liver following exposure to anti-malarial drugs: amodiaquine and sulphadoxine-pyrimethamine.Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.Studies on copper metabolism. XIV. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration.The association of hepatolenticular degeneration with schizophrenia. A review of the literature and case report.A genetic study of Wilson's disease: evidence for heterogeneity.Development of gamma G, gamma A, gamma M, beta IC-beta IA, C 1 esterase inhibitor, ceruloplasmin, transferrin, hemopexin, haptoglobin, fibrinogen, plasminogen, alpha 1-antitrypsin, orosomucoid, beta-lipoprotein, alpha 2-macroglobulin, and prealbuminObservations on ceruloplasmin in Wilson's disease.Clinical implications of plasma fractionation.Cirrhosis of the liver induced by cupric nitrilotriacetate in Wistar rats. An experimental model of copper toxicosis.Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.Trace Elements in Human Nutrition.The screening of hereditary metabolic defects among newborn infantsThe course of Wilson's disease (hepatolenticular degeneration) during pregnancy and after delivery.Cytochrome oxidase deficiency in Wilson's disease: a suggested ceruloplasmin function.Reduced oxidase activity in the caeruloplasmin of two families with Wilson's diseaseCopper metabolism in normal adults and in clinically normal relatives of patients with Wilson's disease.A family study of the biochemical defects in Wilson's disease.Placental expression of ceruloplasmin in pregnancies complicated by severe preeclampsiaTranscriptional dysregulation in a transgenic model of Parkinson disease.Dimercaprol in the pre-neurological stage of Wilson's disease (hepatolenticular degeneration).Role of the syncytium in placenta-mediated complications of preeclampsia.Advances in the understanding of mammalian copper transporters.Pathogenesis and management of Wilson disease.
P2860
Q24564471-0AA2931B-B078-4FDD-94D6-071CD446FE63Q24628397-D53C4D88-4777-4916-9FAA-3D6079970287Q24647056-D388A93C-9503-43D1-9B2E-262DB7E57DF7Q28539339-A82FCD6F-CA4A-4308-BFAA-49DF059EEF16Q33627961-C2157395-6FF1-48BE-8655-AC98E4BE6AEFQ33670250-1B4AEC44-57D3-42E0-BD18-81EE8A2797FBQ33709983-1D863193-466A-4EC4-ACB4-BCC2D13DEBB0Q33731488-85949D61-3A45-4DB7-B4F6-1349F9D3E4CBQ33731827-B1F96FA3-CADC-4284-8A17-FAF254475CC6Q33731862-8EC6D69D-C82C-4D2E-983F-AA9617D3F272Q33768699-708F8F3C-7725-4932-BBF2-F610993342D4Q33956393-5F78D602-C8D8-4F44-B0E2-BDD54BF6D2E9Q34008993-90D174DD-845E-4684-8ED9-7F1230068376Q34010551-76F0561D-45EE-48C5-B8D4-401A67ED1B70Q34269753-9D37180E-0200-4DDA-936B-4879565DE7B9Q34340246-78C97CCF-FA93-445D-8F00-D4FA9B3B1F58Q34751964-327FCCEE-7141-4771-A9BB-92949E12FC4FQ35038613-CD8CDB93-006E-428E-8366-A19B9DC4312BQ35288913-2BA2BC17-B258-4A9B-9716-97A78DA8E58DQ35292378-078A4A67-7B38-409F-B2E7-F0EDAE915E65Q35330805-377695A1-CEF0-4471-A8C5-E01A8C4CDBC7Q35569385-03834858-7A79-4C3B-9DF3-66413F8C524DQ35572101-F12FEFBC-D9DB-476A-808F-65361ABCED7EQ35636613-FB09CBDE-E845-4F02-BB14-F72E84728409Q35649708-E0C1FC30-2EAA-4F3C-AA4F-4E4E16FA00FCQ35817012-8C512268-2F92-4651-B0D8-023E519772E0Q35817192-7A275215-56F2-4280-B5A8-8EE340EB6E65Q35895665-5D05C262-0CF5-4F34-9260-22E0E20F0E0CQ35917960-C11FD51C-F354-46F9-BA83-B224674DDCD7Q35922879-316BEB84-E4C6-4CDF-BB5B-846B15F306CBQ36450857-30C087B0-70A0-4F69-8111-FD70063AFA41Q36615959-DA70C18F-2E7E-4748-8C05-D49FE8C12F1EQ36702498-918224D3-787E-4507-BA0F-E97C99A02FE9Q36713072-1C6A7A12-F523-4292-A9F7-89014A691C3FQ37193882-E8A67D9A-B4B8-4C53-A3A5-713C2BAC9E1BQ37254999-142FD3E6-4900-4DE1-85A3-9FE5753C39F9Q37273295-2839E55F-8C7C-4593-A6C0-F38B561CE89AQ37394622-E05C7AE7-21CA-4FAD-A2A1-75A869D1439FQ37983830-32129CB8-C5DC-4DF3-888D-D8854252A26CQ38180820-B3BDEAA0-242F-479D-82DA-4B69864212B9
P2860
Deficiency of ceruloplasmin in patients with hepatolenticular degeneration (Wilson's disease).
description
1952 nî lūn-bûn
@nan
1952 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1952 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1952年の論文
@ja
1952年論文
@yue
1952年論文
@zh-hant
1952年論文
@zh-hk
1952年論文
@zh-mo
1952年論文
@zh-tw
1952年论文
@wuu
name
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@ast
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@en
Deficiency of ceruloplasmin in patients with hepatolenticular degeneration
@nl
type
label
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@ast
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@en
Deficiency of ceruloplasmin in patients with hepatolenticular degeneration
@nl
prefLabel
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@ast
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@en
Deficiency of ceruloplasmin in patients with hepatolenticular degeneration
@nl
P1433
P1476
Deficiency of ceruloplasmin in ...... generation (Wilson's disease).
@en
P2093
SCHEINBERG IH
P304
P356
10.1126/SCIENCE.116.3018.484
P407
P577
1952-10-01T00:00:00Z